Roger Løvlie • 1971 • Torvastad • 10 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
R ROLOGEN AS	Managing Director/CEO	-	4,615,615	100 % directly
L LIANLO AS	Managing Director/CEO	457,054	1,109,091	100 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
R ROLOGEN AS	Chairman	-	4,615,615	100 % directly
L LIANLO AS	Chairman	457,054	1,109,091	100 % indirectly
C COLOALERT AS	Board Member	-	3,864,575	33.33 % indirectly
U UNI TARGETING RESEARCH AS	Board Member	2,523,951	2,480,972	31.3 % indirectly
E EUROPEAN ONCOLOGY LAB AS	Board Member	93,500	-27,130	31.3 % indirectly
R ROGER LØVLIE GENECONSULT	Holder	-	-	-
T TORVASTAD ARENA AS	Board Member	1,769,431	7,450,080	-
F FRIBU KARMØY	Board Member	-	-	-

Last update: Feb 24, 2026

Related industries2

Direct relationships5

DS
Dagfinn Steinar Øgreid1956
EUROPEAN ONCOLOGY LAB AS, COLOALERT AS, UNI TARGETING RESEARCH AS
HJ
Hans Johan Hekland1958
EUROPEAN ONCOLOGY LAB AS, COLOALERT AS, UNI TARGETING RESEARCH AS
AA
Arne Alf Haldorsen1948
TORVASTAD ARENA AS
KV
Kjetil Vikingstad1971
TORVASTAD ARENA AS
LØ
Lars Øystein Folkedal1969
FRIBU KARMØY

Shares owned by Roger Løvlie

Name	Share class	Total operating income	Total equity	Share
R ROLOGEN AS	Ordinære aksjer	0	4,615,615	100 % directly
L LIANLO AS		457,054	1,109,091	100 % indirectly
C COLOALERT AS		0	3,864,575	33.33 % indirectly
E EUROPEAN ONCOLOGY LAB AS		93,500	-27,130	31.3 % indirectly
U UNI TARGETING RESEARCH AS		2,523,951	2,480,972	31.3 % indirectly
B BRACOM AS		158,176,540	53,317,240	1.93 % indirectly
B BRACOM MICROTRENCHING AS Closed		29,016,781	532,344	1.93 % indirectly
D DEEPX HEALTH AS	NO0010159700	792,936	141,278,563	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025